TPUC3
Report
- Report Number
- 1823260-2024-02512
- Event Type
- Malfunction
- Date Received
- August 30, 2024
- Date of Event
- August 7, 2024
- Report Date
- February 24, 2025
- Manufacturer
- ROCHE DIAGNOSTICS
- Product Code
- JGQ
- PMA / PMN Number
- K071239
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- KS
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
THE TPUC3 REAGENT EXPIRATION DATE WAS NOT PROVIDED. THE C702 MODULE SERIAL NUMBER WAS (B)(6). THE CUSTOMER USES A 3RD PARTY QC. QC WAS WITHIN THE ASSIGNED RANGES ON THE DAY OF THE EVENT. THE ALARM TRACE SHOWED MULTIPLE ABNORMAL ASPIRATION (SAMPLE PROBE) ALARMS, A SAMPLE CLOT ALARM, AND A COUPLE OF SAMPLE SHORT ALARMS. THE INVESTIGATION IS ONGOING.
THERE WAS FLUCTUATION AT THE BEGINNING OF THE CALIBRATION TRACE BUT THEN IT BECAME STABLE WITHIN SPECIFICATIONS. THE REACTION KINETICS SHOWED A VERY STRONG ABNORMAL COURSE. SUCH CURVES ARE USUALLY TRIGGERED BY GAMMOPATHY. GAMMOPATHY IS INCREASINGLY OBSERVED IN PATIENTS DIAGNOSED WITH CANCER, WHICH WAS SUPPORTED IN THIS EVENT. THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM. THE CAUSE OF THE EVENT WAS CONSISTENT WITH A SAMPLE-RELATED (E.G. GAMMOPATHY) AND A PREANALYTIC ISSUE AT THE CUSTOMER SITE. PREANALYTICS ARE WITHIN THE CUSTOMER'S RESPONSIBILITY.
WE RECEIVED AN ALLEGATION ABOUT DISCREPANT RESULTS FOR 1 PATIENT URINE SAMPLE TESTED WITH TOTAL PROTEIN URINE/CSF GEN.3 (TPUC3) ASSAY ON A COBAS 8000 C702 MODULE. RANDOM RESULT: 21.7 MG/DL. 24 HOURS RESULT: 0.0 MG/DAY. NO QUESTIONABLE RESULT WAS REPORTED OUTSIDE THE LABORATORY. THE RESULT OF 21.7 MG/DL WAS REPORTED OUTSIDE THE LABORATORY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1912248 | TPUC3 | TOTAL PROTEIN | JGQ | ROCHE DIAGNOSTICS | 767916 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Male |